Sana Other Operating Expenses from 2010 to 2024

SANA Stock  USD 2.61  0.26  11.06%   
Sana Biotechnology's Other Operating Expenses is increasing over the years with slightly volatile fluctuation. Other Operating Expenses is expected to dwindle to about 255 M. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2019-12-31
Previous Quarter
52.7 M
Current Value
61.8 M
Quarterly Volatility
40.6 M
 
Covid
Check Sana Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sana Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 25.8 M, Interest Expense of 18.9 M or Selling General Administrative of 46.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.9. Sana financial statements analysis is a perfect complement when working with Sana Biotechnology Valuation or Volatility modules.
  
Check out the analysis of Sana Biotechnology Correlation against competitors.
For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.

Latest Sana Biotechnology's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Sana Biotechnology over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sana Biotechnology. It is also known as Sana Biotechnology overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Sana Biotechnology's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sana Biotechnology's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Sana Other Operating Expenses Regression Statistics

Arithmetic Mean114,103,200
Geometric Mean32,850,304
Coefficient Of Variation123.93
Mean Deviation127,058,640
Median8,221,000
Standard Deviation141,411,043
Sample Variance19997.1T
Range348.7M
R-Value0.84
Mean Square Error6291.8T
R-Squared0.71
Significance0.000085
Slope26,603,321
Total Sum of Squares279959.2T

Sana Other Operating Expenses History

2024255 M
2023325.8 M
2022272.6 M
2021356.9 M
2020286.1 M
2019141.2 M

About Sana Biotechnology Financial Statements

Sana Biotechnology stakeholders use historical fundamental indicators, such as Sana Biotechnology's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Sana Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sana Biotechnology's assets and liabilities are reflected in the revenues and expenses on Sana Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sana Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Operating Expenses325.8 M255 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:
Check out the analysis of Sana Biotechnology Correlation against competitors.
For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.40)
Return On Assets
(0.31)
Return On Equity
(0.93)
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.